Indoco Remedies shares slide after USFDA issues seven Goa plant observations
Indoco Remedies’ shares fell as much as 5.5% on Sept. 7 after the US Food and Drug Administration issued seven observations following an inspection of its Plant II (Sterile) facility in Goa.